Add BrightSurf on Google Email

Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth

A new study found that patients with 4 or 5 identified risk factors, including age 18-24 years and schizophrenia spectrum disorders, had over 100 times the incidence of Neuroleptic Malignant Syndrome. The data provide a basis for early identification and monitoring of children and youth at elevated risk.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Child and Adolescent Psychopharmacology·TypeData/statistical analysis·DateSep 18, 2024

Non-invasive method to predict survival in patients with liver cancer

A recent study found a correlation between higher anti-PD-1 autoantibody levels and lower survival rates in patients with advanced liver cancer, suggesting these autoantibodies as potential biomarkers for predicting treatment response. The discovery aims to improve treatment regimens for patients with liver cancer.

SourceOkayama University·JournalGastro Hep Advances·TypeObservational study·DateSep 18, 2024
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Evidence shows that estrogen blocker treatment does not increase the risk of coronary heart disease in breast cancer patients

New study finds that extended estrogen suppression using aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe and does not increase the risk of coronary artery calcification. The duration of treatment and presence of osteoporosis were not associated with increased coronary artery calcification scores.

SourceElsevier·JournalCanadian Journal of Cardiology·TypeObservational study·DateSep 17, 2024

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

The CABINET trial demonstrates that cabozantinib significantly improves median progression-free survival (PFS) for patients with advanced pancreatic and extra-pancreatic neuroendocrine tumors. The treatment also shows promise across all clinical subgroups, including primary tumor site and grade.

SourceAlliance for Clinical Trials in Oncology·DateSep 16, 2024

A molecular signal works its magic from inside a straitjacket

Researchers at UCSF used cryogenic electron microscopy to study the protein TGF-Beta, which plays a crucial role in development and cancer. They found that TGF-Beta can signal even when bound to a 'straitjacket' within the cell membrane, challenging decades-old dogma on its function.

SourceUniversity of California - San Francisco·JournalCell·DateSep 16, 2024

Breast cancer research: New studies show how post-treatment lifestyle choices shape long-term outcomes after diagnosis

Two studies found breastfeeding after breast cancer diagnosis is safe and feasible for young patients with specific genetic variations, as well as hormone receptor-positive breast cancer survivors. A third study shows a telephone-based coaching program can significantly increase physical activity in overweight patients, potentially imp...

SourceDana-Farber Cancer Institute·DateSep 15, 2024
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

Five key factors predict the response of cancer patients to immunotherapy

A study by IRB Barcelona researchers has identified five independent factors that determine patients' response and survival after receiving checkpoint inhibitors, a type of immunotherapy. These findings provide a framework for current and future biomarkers of immunotherapy response and could lead to more accurate patient classification.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Genetics·TypeComputational simulation/modeling·DateSep 12, 2024

A new type of RNA could revolutionize vaccines and cancer treatments

Researchers at Boston University discovered a new method to harness self-amplifying RNA to create more effective vaccines. The modified saRNA vaccine protected mice from severe COVID-19 disease with a lower dose than current mRNA vaccines. Longer duration of protein expression and reduced inflammation were also observed.

SourceBoston University·JournalNature Biotechnology·TypeExperimental study·DateSep 11, 2024

Evolving the framework of cancer theory

Researchers propose a new approach to understanding cancer evolution, acknowledging the importance of environmental influences and epigenetic changes. By refining the clonal evolution model, they aim to develop more effective cancer therapies that consider the full complexity of cancer cell evolution.

SourceArizona State University·JournalNature Reviews Cancer·TypeLiterature review·DateSep 10, 2024
Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

Melanoma incidence and mortality trends in Sweden

A recent study in Sweden found a significant decline in both melanoma incidence and mortality among individuals aged 30-49. The causes of this downward trend are unclear but may be attributed to increased UV protection, public health campaigns, demographic changes, or advancements in melanoma treatment.

SourceJAMA Network·JournalJAMA Dermatology·DateSep 8, 2024

AI unlocks new path to personalized cancer treatments

Researchers at Auburn University have developed a novel approach integrating artificial intelligence with molecular dynamics simulations and network analysis to enhance the prediction of binding sites on the PD-L1 protein. Their findings could improve immunotherapies like pembrolizumab, revolutionizing cancer treatment.

SourceAuburn University Department of Physics·JournalJournal of the American Chemical Society·TypeExperimental study·DateSep 5, 2024
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

Innovative computational approach yields novel cancer targets

A new study published in Cell Systems uses artificial intelligence to map regulatory networks in patient tumors and identifies four drug candidates for neuroendocrine, liver, and renal cancers. The researchers validated these candidates in cells, showing that inhibiting them significantly affected cancer cell growth.

SourceWeill Cornell Medicine·JournalCell Systems·DateSep 5, 2024

Targeted cancer therapies: Getting radioactive atoms to accumulate in tumors

Researchers developed a novel compound to target prostate cancer using radioactive atom astatine-211, potentially overcoming issues with previous compounds like deastatination. The study found high accumulation in tumors and low accumulation in vital organs, highlighting the potential of this new compound for targeted alpha therapy.

SourceChiba University·JournalEJNMMI Radiopharmacy and Chemistry·TypeExperimental study·DateSep 3, 2024

Researchers discover mechanism that could control longevity, cancer cell production

Researchers at UC Merced used fruit flies to uncover a cellular process that could impact the understanding of cancer and aging. They discovered a mechanism that cells use to tune how much protein they make through the process of translating RNA into protein, which can affect longevity and cancer cell production.

SourceUniversity of California - Merced·JournalNature Communications·TypeObservational study·DateSep 3, 2024
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

Blood stem cell breakthrough could transform bone marrow transplants

Melbourne researchers have developed a breakthrough in creating lab-grown human blood stem cells, which can be used to treat childhood blood disorders. The cells closely mimic those found in the human embryo and can create specific matched blood cells for transplantation, reducing complications and addressing donor shortages.

SourceMurdoch Childrens Research Institute·JournalNature Biotechnology·TypeExperimental study·DateSep 2, 2024

Study combines data, molecular simulations to accelerate drug discovery

Researchers have developed a new method to increase speed and success rates in drug discovery by combining data from the Library of Integrated Network-based Cellular Signatures with targeted docking simulations. This approach can accelerate the drug research process, identifying potentially effective compounds more efficiently.

SourceUniversity of Cincinnati·JournalScience Advances·TypeComputational simulation/modeling·DateAug 30, 2024

Scientists discover how the body's killer cells attack cancer

Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.

SourceUniversity of Southampton·JournalScience Advances·TypeRandomized controlled/clinical trial·DateAug 28, 2024

JAMA review highlights advances in kidney cancer research and care

Recent years have seen therapeutic advances in kidney cancer due to deeper understanding of the disease's biology, with improved treatments and early detection contributing to decreased deaths. Cigarette smoking and being overweight remain major risk factors for kidney cancer.

SourceUniversity of North Carolina Health Care·JournalJAMA·TypeMeta-analysis·DateAug 28, 2024

Old chemo drug, new pancreatic cancer therapy?

Researchers have discovered a new approach to treating pancreatic ductal adenocarcinoma (PDAC), a rare type of pancreatic cancer. Folinic acid has been found to weaken the cancer's defenses by elevating levels of anti-cancer immune molecules, enabling a more effective immune response and slower tumor growth.

SourceCold Spring Harbor Laboratory·JournalProceedings of the National Academy of Sciences·DateAug 26, 2024
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Chinese Medical Journal study reframes guidelines for transarterial chemoembolization refractoriness in hepatocellular carcinoma treatment

The Chinese College of Interventionalists has introduced a consensus statement on TACE refractoriness in hepatocellular carcinoma, providing a framework for clinicians to identify and manage the condition. This move aims to optimize treatment strategies and improve patient outcomes, particularly in China where HCC incidence is high due...

SourceCactus Communications·JournalChinese Medical Journal·TypeSurvey·DateAug 20, 2024

New anti-CKAP4 antibodies deliver hope for pancreatic cancer treatment

Researchers from Osaka University have developed a humanized antibody that blocks the DKK1–CKAP4 pathway, stimulating cancer cell growth. The new anti-CKAP4 antibody suppressed tumor formation in mice with both human and mouse tumors, as well as modulating anti-tumor immune reactions.

SourceOsaka University·JournalCancer Science·TypeExperimental study·DateAug 20, 2024

Korea University offers new breakthrough for Hepatitis C to improve life expectancy

A new study by Korea University College of Medicine shows that direct-acting antivirals significantly reduce liver-related clinical outcomes and lower the risk of disease progression to cancer or cirrhosis, increasing life expectancy for patients with Hepatitis C. The treatment approach has a high effectiveness rate of 90%.

SourceKorea University College of Medicine·JournalEClinicalMedicine·TypeData/statistical analysis·DateAug 20, 2024

Role of the gut barrier in colorectal cancer treatment

Researchers discuss the role of gut microbiota in regulating basal inflammation levels and promoting healing of the bowel after surgery. Weakened gut barrier function may lead to persistent low-grade inflammation and increased risk of cancer recurrence.

SourceImpact Journals LLC·JournalOncotarget·TypeSystematic review·DateAug 19, 2024

Child-parent therapy has biological benefits for traumatized kids

A new study from UCSF finds that child-parent psychotherapy can reduce biological age acceleration in children who have experienced trauma. The treatment group showed significantly less age-related change than the comparison group, with potential implications for long-term health outcomes.

SourceUniversity of California - San Francisco·JournalPsychological Science·DateAug 14, 2024
Fluke 87V Industrial Digital Multimeter

Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.

Microscopic packets could deliver diabetes-preventing therapeutics

Texas A&M researchers are investigating the use of extracellular vesicles to deliver immune-suppressing proteins, potentially reducing the immune system's attack on insulin-producing beta-cells. The goal is to develop a novel treatment for type 1 diabetes, which currently has only lifelong insulin therapy as an approved option.

SourceTexas A&M University·DateAug 14, 2024

Surprising insight into cancer comes from unique plant species that find different solutions to evolutionary challenges

Researchers studied three polyploid plant species that successfully adapted to extra DNA and found distinct molecular solutions. The study identified the CENP-E molecule as a promising target for killing polyploid cancers. Additionally, 'meiosis genes' were found to play a crucial role in rapid adaptation to polyploidy.

SourceUniversity of Nottingham·JournalCell Reports·TypeExperimental study·DateAug 13, 2024

An appetizer can stimulate immune cells’ appetite, a boon for cancer treatments

Researchers at UC Santa Barbara discovered that macrophages can be programmed to respond to light, triggering an increase in their appetite and improving the effectiveness of cancer immunotherapies. The findings offer a new way to enhance trained immunity, a type of memory exhibited in the innate immune system.

SourceUniversity of California - Santa Barbara·JournalDevelopmental Cell·DateAug 12, 2024

A simple test can predict whether smokers will manage to quit

Researchers found that a simplified two-question test can predict smoking abstinence in cancer patients with equal accuracy as the full Fagerström Test. However, the test may not work well for Non-Hispanic Black people with a cancer diagnosis. The study aims to help doctors tailor tests for different groups.

SourceNorwegian University of Science and Technology·JournalNicotine & Tobacco Research·TypeObservational study·DateAug 12, 2024
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Newly discovered mechanism halts tumor cell replication

Researchers at the University of Bologna have identified a specific location and genomic context where DNA breaks occur due to topoisomerase I inhibition. This discovery could lead to new cancer treatments by inducing DNA damage and genomic instability in cancer cells.

SourceUniversità di Bologna·JournalScience Advances·DateAug 8, 2024

Demystifying APE1: New findings on direct activation of ATM signaling by DNA single-strand breaks

Researchers have made significant progress in understanding the function of APE1 in DNA damage response, showing that it promotes SSB-induced ATM DDR through two mechanisms. The study provides direct evidence for APE1's active role in activating ATM kinase to promote the repair of single-strand DNA damage.

SourceUniversity of North Carolina at Charlotte·JournalNature Communications·TypeExperimental study·DateAug 7, 2024
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Algorithm helps doctors identify more aggressive types of basal cell carcinoma

A new clinical algorithm developed at the University of Gothenburg can accurately identify highly aggressive forms of basal cell carcinoma. The algorithm uses a combination of clinical and dermoscopic images to distinguish between low-risk and high-risk tumors, allowing for more effective treatment and better patient outcomes.

SourceUniversity of Gothenburg·JournalDermatology Practical & Conceptual·TypeObservational study·DateJul 30, 2024
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

Lower dose prostate cancer treatments retain efficacy while improving tolerability

Researchers found that lower doses of radiopharmaceutical therapy approaches for metastatic castrate-resistant prostate cancer were just as effective as the standard dose, with better tolerability among patients. The study showed improved PSA response rates and comparable median overall survival in both groups.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJul 24, 2024

New protein discovery may influence future cancer treatment

Researchers have discovered a protein function that could guide novel cancer treatment options and improve diagnostic procedures for various cancers. The tumour-suppressing protein p16 has the ability to dramatically alter its structure and function, with potential implications for cancer formation and therapy response.

SourceUniversity of Otago·JournalNature Communications·DateJul 24, 2024

NYU Abu Dhabi researchers discover tumor suppressor protein Par-4 triggers unique cell death pathway in cancerous cells

Researchers at NYU Abu Dhabi have discovered that the tumor suppressor protein Par-4 can cause a unique type of cell death called ferroptosis in human glioblastoma cells, while sparing healthy cells. This new understanding has the potential to inform the development of novel treatments for various hard-to-treat cancers and neurodegener...

SourceNew York University·JournalCommunications Biology·DateJul 23, 2024

When tumors collide: Analysis of mixed-type breast cancer reveals complexity

Researchers analyzed collision-type mixed ductal-lobular breast cancers and found that IDC and ILC regions had distinct gene expression profiles. The study reveals tremendous variation within this already highly variable disease, highlighting the need for personalized treatments.

SourceUniversity of Pittsburgh·JournalProceedings of the National Academy of Sciences·TypeCase study·DateJul 23, 2024
Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

Improving the design of mRNA-loaded nanocarriers for targeted therapies

Scientists improve stability and bioavailability of mRNA nanocarriers using triphenylphosphonium, leading to increased protein production in tumor tissues. The TPP-based system also shows higher mRNA levels in blood after 30 minutes compared to amine-based micelles.

SourceTokyo Institute of Technology·JournalMaterials Horizons·TypeExperimental study·DateJul 22, 2024

Key driver for epithelial cancer development identified

A distinct TNF-α signaling program has been identified as a key driver of epithelial cancer development, contributing to cell proliferation and invasion. The researchers found that this program is active in both normal tissues and tumors, but its level of activity correlates with tumor aggressiveness.

SourceUniversity of Zurich·JournalNature·TypeExperimental study·DateJul 17, 2024
Sky & Telescope Pocket Sky Atlas, 2nd Edition

Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.

Caught in the actinium

Researchers grew crystals containing actinium and studied its atomic structure, revealing how it interacts with surrounding atoms. The study could help design better targeted alpha therapy for cancer treatment.

SourceDOE/Lawrence Berkeley National Laboratory·JournalNature Communications·DateJul 15, 2024
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

MSK discovery suggests opportunity to improve effectiveness of KRAS inhibitors against pancreatic cancer

Researchers at Memorial Sloan Kettering Cancer Center have identified a new mechanism of resistance to KRAS inhibitors in pancreatic cancer, suggesting an opportunity to make the treatment more effective. The study found that a more aggressive subtype of pancreatic tumor is likely to respond well to KRAS inhibitors.

SourceMemorial Sloan Kettering Cancer Center·JournalCancer Discovery·TypeExperimental study·DateJul 11, 2024

Researchers customize AI tools for digital pathology

Scientists developed customized AI tools, including ChatGPT, to provide accurate responses on digital pathology. The tools help pathologists without extensive coding experience analyze tissue samples, bridging the gap between pathology and digital pathology skills.

SourceWeill Cornell Medicine·JournalThe Lancet Digital Health·DateJul 10, 2024

Blood cancer drug could make radiotherapy on brain tumours more effective

Researchers at the University of Plymouth have discovered that administering a HDAC6 inhibitor prior to radiotherapy can inhibit cellular growth and increase cell death in meningioma samples. This promising approach could lead to improved treatment outcomes for malignant meningioma patients.

SourceUniversity of Plymouth·JournalEBioMedicine·TypeExperimental study·DateJul 10, 2024
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

Implantable LED device uses light to treat deep-seated cancers

Researchers at the University of Notre Dame have developed a wireless LED device that can be implanted to treat deep-seated cancers. The device, combined with a light-sensitive dye, destroys cancer cells and triggers an immune response against them.

SourceUniversity of Notre Dame·JournalPhotodiagnosis and Photodynamic Therapy·DateJul 9, 2024

The role of RNF114B, a key gene in the progression and treatment of lung adenocarcinoma, has been discovered

The study identified RNF144B as a tumour suppressor that prevents genomic instability, but low expression leads to poor prognosis and treatment resistance in lung adenocarcinoma. The research suggests that even non-mutated genes like RNF144B can have a significant impact on cancer development.

SourceUniversitat Pompeu Fabra - Barcelona·JournalJournal of Experimental & Clinical Cancer Research·TypeExperimental study·DateJul 8, 2024

Uncovering “Blockbuster T cells” in the gut wins NOSTER & Science Microbiome Prize

Researchers have identified a novel type of T cell that can recognize and respond to multiple bacterial strains in the gut. This breakthrough finding has significant implications for treating diseases such as cancer and inflammatory bowel disease. The discovery was made by Kazuki Nagashima, winner of the NOSTER & Science Microbiome Prize.

SourceAmerican Association for the Advancement of Science (AAAS)·JournalScience·DateJul 4, 2024

Bowel cancer turns genetic switches on and off to outwit the immune system

Researchers found that bowel cancer cells can regulate their growth using genetic on-off switches, allowing them to maximize survival chances. The study also showed that DNA repair genes can be repeatedly created and repaired, acting as 'genetic switches' to control tumour growth or put the brakes back on.

SourceUniversity College London·JournalNature Genetics·TypeExperimental study·DateJul 3, 2024
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.